BlackRock Advisors’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $9K | Hold |
13
| – | – | ﹤0.01% | 3504 |
|
|
2016
Q3 | $14K | Hold |
13
| – | – | ﹤0.01% | 3454 |
|
|
2016
Q2 | $10K | Hold |
13
| – | – | ﹤0.01% | 3517 |
|
|
2016
Q1 | $9K | Hold |
13
| – | – | ﹤0.01% | 3526 |
|
|
2015
Q4 | $12K | Hold |
13
| – | – | ﹤0.01% | 3537 |
|
|
2015
Q3 | $14K | Hold |
13
| – | – | ﹤0.01% | 3538 |
|
|
2015
Q2 | $26K | Hold |
13
| – | – | ﹤0.01% | 3401 |
|
|
2015
Q1 | $12K | Hold |
13
| – | – | ﹤0.01% | 3492 |
|
|
2014
Q4 | $13K | Sell |
13
-68
| -84% | -$68K | ﹤0.01% | 3532 |
|
|
2014
Q3 | $84K | Hold |
81
| – | – | ﹤0.01% | 3063 |
|
|
2014
Q2 | $156K | Sell |
81
-6
| -7% | -$11.6K | ﹤0.01% | 2761 |
|
|
2014
Q1 | $187K | Buy |
87
+69
| +383% | +$148K | ﹤0.01% | 2652 |
|
|
2013
Q4 | $41K | Sell |
18
-20
| -53% | -$45.6K | ﹤0.01% | 3258 |
|
|
2013
Q3 | $109K | Buy |
38
+26
| +217% | +$74.6K | ﹤0.01% | 2898 |
|
|
2013
Q2 | $109K | Buy |
+12
| New | +$109K | ﹤0.01% | 2841 |
|